Combination vaccines in case of allergies or short supply
Based on the data they collected, the researchers have come to the conclusion that combination vaccines are a valid option. The combination is even more effective than two doses of the AstraZeneca vaccine, and might be used, for example, in individuals with allergies or if there are bottlenecks with supplies. The researchers also hope that the combination vaccine will be a further building block that can be used to improve the overall effectiveness of the Covid-19 vaccination. However, more studies are required to confirm the safety and clinical effectiveness of using this and other combination vaccines.
The study was able to be carried out so quickly thanks to assistance from several different parties: the Bavarian State Ministry of Science and the Arts as part of the CoVaKo-2021 project and the FOR-COVID consortium, the German Centre for Infection Research (DZIF) and the vaccination network VACCELERATE (funded by the EU programme Horizon 2020). The aim of CoVaKo-2021 and FOR-COVID is for scientists to monitor the introduction of Covid-19 vaccinations in Bavaria. The study was mainly conducted by the three principal investigators Prof. Dr. Ulrike Protzer from Munich, Prof. Dr. Klaus Überla from Erlangen and Prof. Dr. Oliver Cornely from Cologne.
Bernd Sibler, Bavarian State Minister for Science and the Arts, emphasises: “The results of this study have a direct impact on our vaccination strategy. They help us to use vaccinations as effectively as possible and act as an important basis for political decisions regarding our vaccination strategy in the future. The work of our scientists at the Faculty of Medicine and the university hospitals is indispensable for finding a way out of the Covid-19 pandemic.”